ENDONOVO THERAPEUTICS, INC. (ENDV) Operating cash flow 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$678,838FY2022 · since FY2013: -$257,416 → -$678,838
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$678,838 | +31.2% |
| FY2021 | -$986,584 | -33.0% |
| FY2020 | -$741,590 | +70.8% |
| FY2019 | -$2.5M | +11.7% |
| FY2018 | -$2.9M | +3.7% |
| FY2017 | -$3.0M | -21.4% |
| FY2016 | -$2.5M | -141.6% |
| FY2015 | -$1.0M | -12.1% |
| FY2014 | -$909,296 | -253.2% |
| FY2013 | -$257,416 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENDV financial trends
ENDV RevenueENDV Net incomeENDV Net marginENDV Gross profitENDV Gross marginENDV Operating incomeENDV Operating marginENDV Free cash flowENDV Capital expendituresENDV Return on equityENDV Stock buybacksENDV Dividends paidENDV Total assetsENDV Total liabilitiesENDV Shareholders’ equityENDV overview →